CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis

CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis

Background: The purpose of this study was to determine whether plasma levels of the collagen triple helix repeat containing 1 (CTHRC1) protein can serve as a blood-based biomarker for improved diagnosis of rheumatoid arthritis (RA) patients and monitoring of RA disease activity.Methods: We measured...

Full description

Bibliographic Details
Main Authors: Askhat Myngbay, Yergali Bexeitov, Altynai Adilbayeva, Zhenisbek Assylbekov, Bogdan P. Yevstratenko, Rysgul M. Aitzhanova, Bakhyt Matkarimov, Vyacheslav A. Adarichev, Jeannette Kunz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
biomarker
collagen triple helix repeat containing 1
(CTHRC1)
rheumatoid factor (RF)
anti-citrullinated protein antibodies (ACPA)
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01353/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01353/full

Similar Items